A little after 10 p.m. last night, Injective made a pretty ambitious move.
It signed an MoU with South Korean custodian BDACS: KRW1, a Korean won stablecoin, is set to become the exclusive won settlement asset for Injective’s on-chain RWA business.
In plain English: from now on, Korean institutions could trade tokenized assets on Injective directly in won, without first converting to USDT or USDC and going the long way around.
The really interesting part isn’t Injective. It’s South Korea.
Stablecoins on South Korea’s five major exchanges have seen net outflows to overseas platforms for 18 consecutive months, totaling $10.4 billion. Money has kept flowing toward the dollar, and Injective is now trying to catch some of that flow in the other direction. Getting there first doesn’t guarantee a win, but if you don’t get there first, you’re definitely out of the running.
Still, it’s worth keeping a cool head. The key words are “proposed” and “subject to regulatory approval”: KRW1 minting and redemption will be available only to approved institutions, and it hasn’t launched yet. South Korea’s Digital Asset Basic Act won’t be finalized until the end of the year. For now, this is a placeholder, not a launch.
The market is being pretty honest about it, too: after the news, INJ surged to 9.18, then gave it all back within two hours, falling to around 8.6. It’s now just above 9, and hasn’t even touched the previous high of 9.41 from October 16. The good news was already priced in; what’s left is to see it delivered.
Keep an eye on three things: whether regulators approve it, which institutions are first to come on board, and whether on-chain won settlement volume takes off.
$INJ
It signed an MoU with South Korean custodian BDACS: KRW1, a Korean won stablecoin, is set to become the exclusive won settlement asset for Injective’s on-chain RWA business.
In plain English: from now on, Korean institutions could trade tokenized assets on Injective directly in won, without first converting to USDT or USDC and going the long way around.
The really interesting part isn’t Injective. It’s South Korea.
Stablecoins on South Korea’s five major exchanges have seen net outflows to overseas platforms for 18 consecutive months, totaling $10.4 billion. Money has kept flowing toward the dollar, and Injective is now trying to catch some of that flow in the other direction. Getting there first doesn’t guarantee a win, but if you don’t get there first, you’re definitely out of the running.
Still, it’s worth keeping a cool head. The key words are “proposed” and “subject to regulatory approval”: KRW1 minting and redemption will be available only to approved institutions, and it hasn’t launched yet. South Korea’s Digital Asset Basic Act won’t be finalized until the end of the year. For now, this is a placeholder, not a launch.
The market is being pretty honest about it, too: after the news, INJ surged to 9.18, then gave it all back within two hours, falling to around 8.6. It’s now just above 9, and hasn’t even touched the previous high of 9.41 from October 16. The good news was already priced in; what’s left is to see it delivered.
Keep an eye on three things: whether regulators approve it, which institutions are first to come on board, and whether on-chain won settlement volume takes off.
$INJ